Clinical Trial Detail

NCT ID NCT03071874
Title Phase II Study Of Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

meningioma

Therapies

Vistusertib

Age Groups: senior adult

No variant requirements are available.